HIGHLIGHTS
- who: David J. Thomson from the University of of Cancer Research, London, United Kingdom have published the article: TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer, in the Journal: (JOURNAL)
- how: Due to differences in the more complex nature of the DNA damage produced by protons vs photons the following hypotheses are made
- future: The collection of all pre-accrual (benchmarking) and during-accrual (recruited patients) DICOM-RT and associated non-DICOM data will underpin future studies to validate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.